Related Experiment Video

Updated: Apr 30, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

2.2K

Hypoglycemia induced by insulin as a triggering factor of cognitive deficit in diabetic children

Vanessa Rodrigues Vilela1, Any de Castro Ruiz Marques1, Christiano Rodrigues Schamber1

  • 1Department of Pharmacology and Therapeutics, State University of Maringá, 87020-900 Maringá, PR, Brazil.

Thescientificworldjournal
|May 3, 2014
PubMed

Insights

Hypoglycemia in children with type 1 diabetes can cause cognitive deficits. Managing blood sugar levels and educating families are crucial for preventing brain damage and cognitive decline.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Neuroscience

Background:

  • Type 1 diabetes mellitus (T1DM) affects children globally.
  • Insulin therapy is essential for T1DM management but can lead to hypoglycemia.
  • Hypoglycemia is a known risk factor for neurological complications.

Purpose of the Study:

  • To review the impact of insulin-induced hypoglycemia on cognitive function in children with T1DM.
  • To identify factors contributing to cognitive deficits in this population.
  • To highlight the relationship between hypoglycemia, brain damage, and cognitive performance.

Main Methods:

  • Systematic literature review of publications from 1961 to 2013.
  • Inclusion of studies on human subjects with T1DM.
  • Exclusion of studies using experimental animal models.

Main Results:

  • Cognitive deficits in children with T1DM are multifactorial.
  • Hypoglycemia's impact is influenced by episode duration, intensity, severity, and frequency.
  • Early onset of T1DM is linked to increased risk of severe hypoglycemia and cognitive impairment.
  • A significant correlation exists between hypoglycemia-induced brain damage and cognitive deterioration.

Conclusions:

  • Insulin-induced hypoglycemia is a significant trigger for cognitive deficits in children with T1DM.
  • Age at diagnosis and hypoglycemia characteristics are critical factors.
  • Enhanced monitoring and education are vital for preventing and managing hypoglycemia in pediatric T1DM patients.

More Related Videos

Hippocampal Insulin Microinjection and In vivo Microdialysis During Spatial Memory Testing10:32

Hippocampal Insulin Microinjection and In vivo Microdialysis During Spatial Memory Testing

Published on: January 11, 2013

16.1K
Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy08:47

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

12.6K

Related Concept Videos

Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
30
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
26
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
45